logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10016465 B1

PDFFull Text
Date of Patent:
Jul. 10, 2018

Filed:

Oct. 10, 2014

Cured gel and method of making

Applicant:

Atrium Medical Corporation, Hudson, NH (US);

Inventors:

Roger Labrecque, Londonderry, NH (US);

Philip McNamara, Concord, NH (US);

Joseph Ferraro, Londonderry, NH (US);

Lisa Rogers, Londonderry, NH (US);

Paul Martakos, Pelham, NH (US);

Theodore Karwoski, Hollis, NH (US);

Steve A. Herweck, Nashua, NH (US);

Keith M. Faucher, Nashua, NH (US);

Thomas M. Swanick, Hillsborough, NH (US);

Assignee:

ATRIUM MEDICAL CORPORATION, Merrimack, NH (US);

Attorney:

Wesley Scott Ashton

Primary Examiner:

Michael G Hartley

Assistant Examiner:

Nabila Ebrahim

Int. Cl.
CPC ...
A61K 47/14 (2017.01); A61K 47/22 (2006.01); A61L 31/08 (2006.01); A61K 31/16 (2006.01); A61M 1/12 (2006.01); A61K 35/60 (2006.01); A61F 13/02 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/225 (2006.01); A61K 31/355 (2006.01); A61K 47/12 (2006.01); A61L 2/07 (2006.01); A61L 2/08 (2006.01); A61L 2/20 (2006.01); A61L 27/36 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61L 31/00 (2006.01); A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61K 38/13 (2006.01); A61F 2/06 (2013.01); B05D 3/06 (2006.01);
U.S. Cl.
CPC ...
A61K 35/60 (2013.01); A61F 13/02 (2013.01); A61F 13/023 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 31/225 (2013.01); A61K 31/355 (2013.01); A61K 38/13 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61L 2/07 (2013.01); A61L 2/081 (2013.01); A61L 2/087 (2013.01); A61L 2/206 (2013.01); A61L 2/208 (2013.01); A61L 27/36 (2013.01); A61L 27/3604 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61L 31/005 (2013.01); A61L 31/10 (2013.01); A61L 31/145 (2013.01); A61F 2/06 (2013.01); A61F 2250/0067 (2013.01); A61L 2202/24 (2013.01); A61L 2300/22 (2013.01); A61L 2300/252 (2013.01); A61L 2300/404 (2013.01); A61L 2300/41 (2013.01); A61L 2300/414 (2013.01); A61L 2300/42 (2013.01); A61L 2300/602 (2013.01); B05D 3/067 (2013.01);
Abstract

A cured non-polymeric gel including a plurality of non-polymeric cross-links. The non-polymeric cross-links result from curing an oil or oil composition at selected curing conditions to achieve a desired amount of cross-linking to form the non-polymeric get. The desired amount of cross-linking is selected based on a desired rate of degradation of the gel after the gel is implanted. The oil or oil composition comprises one or more of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or alphalinolenic acid (ALA).

Find Patent Forward Citations

Loading…